INTERPARFUMS, INC. Cost of Revenue
INTERPARFUMS, INC. (IPAR) reported Cost of Revenue of $117.51 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Expense Statement
us-gaap:CostOfGoodsAndServicesSold · last filed 2026-08-04
- INTERPARFUMS, INC. cost of goods and services sold for the quarter ending 2026-06-30 was $117.51M, a 4.13% increase year-over-year.
- INTERPARFUMS, INC. cost of goods and services sold for the quarter ending 2026-03-31 was $120.25M, a 2.11% decline year-over-year.
- INTERPARFUMS, INC. cost of goods and services sold for the quarter ending 2025-12-31 was $148.84M, a 15.86% increase year-over-year.
- INTERPARFUMS, INC. cost of goods and services sold for the quarter ending 2025-09-30 was $156.76M, a 2.15% increase year-over-year.
- INTERPARFUMS, INC. cost of goods and services sold for fiscal 2025 was $541.29M, a 3.11% increase from fiscal 2024.
- INTERPARFUMS, INC. cost of goods and services sold for fiscal 2024 was $524.98M, a 9.69% increase from fiscal 2023.
- INTERPARFUMS, INC. cost of goods and services sold for fiscal 2023 was $478.60M, a 22.02% increase from fiscal 2022.
- INTERPARFUMS, INC. cost of goods and services sold for fiscal 2022 was $392.23M, a 21.58% increase from fiscal 2021.
| Period end | Cost of Goods and Services Sold 3 month | Cost of Goods and Services Sold 6 month | Cost of Goods and Services Sold 9 month | Cost of Goods and Services Sold 12 month |
|---|---|---|---|---|
| 2026-06-30 | $117.51M 10-Q · filed 2026-08-04 | $237.76M 10-Q · filed 2026-08-04 | $386.60M derived: sum of 3 quarters · filed 2026-08-04 | $543.36M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $120.25M 10-Q · filed 2026-05-05 | $269.08M derived: sum of 2 quarters · filed 2026-05-05 | $425.85M derived: sum of 3 quarters · filed 2026-05-05 | $538.69M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $148.84M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $305.60M derived: sum of 2 quarters · filed 2026-03-10 | $418.45M derived: sum of 3 quarters · filed 2026-08-04 | $541.29M 10-K · filed 2026-03-10 |
| 2025-09-30 | $156.76M 10-Q · filed 2025-11-05 | $269.61M derived: sum of 2 quarters · filed 2026-08-04 | $392.45M 10-Q · filed 2025-11-05 | $520.92M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $112.85M 10-Q · filed 2026-08-04 | $235.69M 10-Q · filed 2026-08-04 | $364.15M derived: sum of 3 quarters · filed 2026-08-04 | $517.62M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $122.84M 10-Q · filed 2026-05-05 | $251.31M derived: sum of 2 quarters · filed 2026-05-05 | $404.78M derived: sum of 3 quarters · filed 2026-05-05 | $526.25M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $128.47M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $281.93M derived: sum of 2 quarters · filed 2026-03-10 | $403.41M derived: sum of 3 quarters · filed 2026-03-10 | $524.98M 10-K · filed 2026-03-10 |
| 2024-09-30 | $153.47M 10-Q · filed 2025-11-05 | $274.94M derived: sum of 2 quarters · filed 2025-11-05 | $396.52M 10-Q · filed 2025-11-05 | $512.55M derived: sum of 4 quarters · filed 2026-03-10 |
| 2024-06-30 | $121.47M 10-Q · filed 2025-08-05 | $243.05M 10-Q · filed 2025-08-05 | $359.08M derived: sum of 3 quarters · filed 2026-03-10 | $492.04M derived: sum of 4 quarters · filed 2026-03-10 |
| 2024-03-31 | $121.58M 10-Q · filed 2025-05-05 | $237.61M derived: sum of 2 quarters · filed 2026-03-10 | $370.57M derived: sum of 3 quarters · filed 2026-03-10 | $491.41M derived: sum of 4 quarters · filed 2026-03-10 |
| 2023-12-31 | $116.03M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $248.99M derived: sum of 2 quarters · filed 2026-03-10 | $369.83M derived: sum of 3 quarters · filed 2026-03-10 | $478.60M 10-K · filed 2026-03-10 |
| 2023-09-30 | $132.96M 10-Q · filed 2024-11-06 | $253.80M derived: sum of 2 quarters · filed 2024-11-06 | $362.57M 10-Q · filed 2024-11-06 | $473.27M derived: sum of 4 quarters · filed 2025-03-11 |
| 2023-06-30 | $120.84M 10-Q · filed 2024-08-06 | $229.61M 10-Q · filed 2024-08-06 | $340.31M derived: sum of 3 quarters · filed 2025-03-11 | $438.87M derived: sum of 4 quarters · filed 2025-03-11 |
| 2023-03-31 | $108.77M 10-Q · filed 2024-05-07 | $219.47M derived: sum of 2 quarters · filed 2025-03-11 | $318.03M derived: sum of 3 quarters · filed 2025-03-11 | $408.98M derived: sum of 4 quarters · filed 2025-03-11 |
| 2022-12-31 | $110.71M derived: 10-K 12 month − 10-Q/A 9 month · filed 2025-03-11 | $209.27M derived: sum of 2 quarters · filed 2025-03-11 | $300.21M derived: sum of 3 quarters · filed 2025-03-11 | $392.23M 10-K · filed 2025-03-11 |
| 2022-09-30 | $98.56M 10-Q/A · filed 2023-11-09 | $189.50M derived: sum of 2 quarters · filed 2023-11-09 | $281.52M 10-Q/A · filed 2023-11-09 | $360.37M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-06-30 | $90.94M 10-Q · filed 2023-08-08 | $182.96M 10-Q · filed 2023-08-08 | $261.81M derived: sum of 3 quarters · filed 2024-02-27 | $357.07M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-03-31 | $92.02M 10-Q · filed 2023-05-08 | $170.86M derived: sum of 2 quarters · filed 2024-02-27 | $266.13M derived: sum of 3 quarters · filed 2024-02-27 | $341.35M derived: sum of 4 quarters · filed 2024-02-27 |
| 2021-12-31 | $78.84M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $174.11M derived: sum of 2 quarters · filed 2024-02-27 | $249.33M derived: sum of 3 quarters · filed 2024-02-27 | $322.61M 10-K · filed 2024-02-27 |
| 2021-09-30 | $95.27M 10-Q · filed 2022-11-09 | $170.49M derived: sum of 2 quarters · filed 2022-11-09 | $243.77M 10-Q · filed 2022-11-09 | $310.17M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | $75.22M 10-Q · filed 2022-08-09 | $148.50M 10-Q · filed 2022-08-09 | $214.90M derived: sum of 3 quarters · filed 2023-02-28 | $278.34M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | $73.28M 10-Q · filed 2022-05-10 | $139.68M derived: sum of 2 quarters · filed 2023-02-28 | $203.11M derived: sum of 3 quarters · filed 2023-02-28 | $225.78M derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | $66.39M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $129.83M derived: sum of 2 quarters · filed 2023-02-28 | $152.50M derived: sum of 3 quarters · filed 2023-02-28 | $208.28M 10-K · filed 2023-02-28 |
| 2020-09-30 | $63.44M 10-Q · filed 2021-11-08 | $86.10M derived: sum of 2 quarters · filed 2021-11-08 | $141.88M 10-Q · filed 2021-11-08 | $205.00M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | $22.66M 10-Q · filed 2021-08-09 | $78.44M 10-Q · filed 2021-08-09 | $141.56M derived: sum of 3 quarters · filed 2022-03-01 | $218.35M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | $55.78M 10-Q · filed 2021-05-10 | $118.90M derived: sum of 2 quarters · filed 2022-03-01 | $195.69M derived: sum of 3 quarters · filed 2022-03-01 | $254.96M derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | $63.12M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $139.91M derived: sum of 2 quarters · filed 2022-03-01 | $199.18M derived: sum of 3 quarters · filed 2022-03-01 | $267.58M 10-K · filed 2022-03-01 |
| 2019-09-30 | $76.79M 10-Q · filed 2020-11-09 | $136.06M derived: sum of 2 quarters · filed 2020-11-09 | $204.46M 10-Q · filed 2020-11-09 | $264.55M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-06-30 | $59.27M 10-Q · filed 2020-08-10 | $127.67M 10-Q · filed 2020-08-10 | $187.76M derived: sum of 3 quarters · filed 2021-03-01 | $255.83M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-03-31 | $68.40M 10-Q · filed 2020-05-11 | $128.50M derived: sum of 2 quarters · filed 2021-03-01 | $196.56M derived: sum of 3 quarters · filed 2021-03-01 | $250.28M derived: sum of 4 quarters · filed 2021-03-01 |
| 2018-12-31 | $60.09M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $128.16M derived: sum of 2 quarters · filed 2021-03-01 | $181.87M derived: sum of 3 quarters · filed 2021-03-01 | $248.01M 10-K · filed 2021-03-01 |
| 2018-09-30 | $68.07M 10-Q · filed 2019-11-05 | $121.78M derived: sum of 2 quarters · filed 2019-11-05 | $187.92M 10-Q · filed 2019-11-05 | $238.64M derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-06-30 | $53.71M 10-Q · filed 2019-08-05 | $119.85M 10-Q · filed 2019-08-05 | $170.58M derived: sum of 3 quarters · filed 2020-03-02 | $236.63M derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-03-31 | $66.14M 10-Q · filed 2019-05-06 | $116.86M derived: sum of 2 quarters · filed 2020-03-02 | $182.92M derived: sum of 3 quarters · filed 2020-03-02 | $228.12M derived: sum of 4 quarters · filed 2020-03-02 |
| 2017-12-31 | $50.73M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $116.78M derived: sum of 2 quarters · filed 2020-03-02 | $161.98M derived: sum of 3 quarters · filed 2020-03-02 | $214.97M 10-K · filed 2020-03-02 |
| 2017-09-30 | $66.06M 10-Q · filed 2018-11-05 | $111.25M derived: sum of 2 quarters · filed 2018-11-05 | $164.24M 10-Q · filed 2018-11-05 | |
| 2017-06-30 | $45.19M 10-Q · filed 2018-08-07 | $98.18M 10-Q · filed 2018-08-07 | ||
| 2016-12-31 | $194.60M 10-K · filed 2019-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| COTY INC. (COTY) | United States | $2.307B | -3.15 |
| e.l.f. Beauty, Inc. (ELF) | United States | $5.934B | |
| EDGEWELL PERSONAL CARE Co (EPC) | United States | $1.261B | -13.27 |
| SOLESENCE, INC. (SLSN) | United States | $0.058B | -25.13 |
| Axil Brands, Inc. (AXIL) | United States | $0.042B | 17.24 |
| UNITED GUARDIAN INC (UG) | United States | $0.034B | 13.30 |
| Caring Brands, Inc. (CABR) | United States | $0.013B | |
| BONK, INC. (BNKK) | United States | $0.011B | -0.14 |
| cbdMD, Inc. (YCBD) | United States | $0.005B | -2.59 |
| Kenvue Inc. (KVUE) | United States | $33.844B | 22.14 |